Skip to Main Content
Legislation Search

H.R. 6077: Healthcare Education in AI Literacy Act

This bill, known as the **Healthcare Education in AI Literacy Act** or **HEAL-AI Act**, aims to amend the Public Health Service Act to enhance the education and training of medical students, residents, and faculty in the application of artificial intelligence (AI) within the medical field. Here are the key components of the bill:

Establishment of Grant Program

The bill calls for the creation of a grant program overseen by the Secretary of Health and Human Services. The purpose of this program is to provide funding to qualified medical schools and residency sponsoring institutions. The grants will be used specifically for:

  • Educating medical students and residents about AI.
  • Training medical faculty on how to effectively incorporate AI into healthcare practices.

Eligibility for Grants

To be eligible for a grant, a medical school or residency institution must demonstrate:

  • The need for AI literacy in their curriculum.
  • A clear plan for using the funds to enhance AI education.

Each grant can provide up to **$100,000**, and priority is given to institutions serving medically underserved communities.

Use of Funds

Grant funds may be used for a variety of purposes related to AI education, including:

  • Developing training programs for AI in medical diagnostics and treatment recommendations.
  • Integrating AI tools into clinical decision-making processes.
  • Understanding ethical considerations associated with AI in healthcare.
  • Conducting educational demonstrations to show practical AI applications in medicine.

It is also stipulated that no more than **10%** of the grant can be allocated for administrative costs.

Reporting Requirements

Institutions receiving grants will be required to submit annual reports, which must include:

  • Progress on educational goals funded by the grant.
  • Details on how the grant funds were spent.
  • Integration of AI education into existing curricula.
  • Enrollment and completion statistics for courses funded by the grant.

Additionally, educational materials developed with grant funding must be made publicly available online.

Funding Authorization

The bill authorizes **$1,000,000** per fiscal year from **2026 through 2030** to support the activities outlined in the legislation.

Collaboration and Geographic Distribution

The bill encourages collaborations with various entities, including academic and nonprofit organizations, to strengthen the AI education curriculum. It also aims to ensure that grants are distributed fairly across different geographic locations, including urban, suburban, and rural areas.

Definitions

The bill provides specific definitions for terms used, including:

  • Artificial Intelligence (AI): A system capable of making predictions or decisions that influence medical environments.
  • Education and Training: Programs focusing on competency-based medical education for enhancing patient care through AI.
  • Qualified Medical Schools: Institutions accredited for medical or osteopathic education.

Renewal of Grants

Institutions that receive grants may apply for renewal to continue their AI education initiatives for additional grant periods.

Relevant Companies

  • MDGL: As a company involved in healthcare innovation, particularly in genomics and AI, it could be affected by the integration of AI in educational practices.
  • CYRX: A company focused on digital health solutions may see implications from collaborations formed under the grant programs established by this legislation.
  • AMGN: As a major biotechnology company, it may collaborate with educational institutions on AI-driven healthcare advancements.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

3 bill sponsors

Actions

2 actions

Date Action
Nov. 18, 2025 Introduced in House
Nov. 18, 2025 Referred to the House Committee on Energy and Commerce.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
David Taylor R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Dec 05, 2025 Dec 03, 2025 -7.71%
Congress pfp
David Taylor R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Dec 05, 2025 Dec 03, 2025 -7.71%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Oct 28, 2025 Oct 24, 2025 +8.21%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $1,001 - $15,000
Oct 03, 2025 Sep 29, 2025 +13.23%
Congress pfp
Lisa C. McClain R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Oct 22, 2025 Sep 25, 2025 +13.83%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Sep 27, 2025 Sep 11, 2025 +8.69%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Full) $1,001 - $15,000
Oct 03, 2025 Sep 04, 2025 +8.36%
Congress pfp
Lisa C. McClain R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 13, 2025 Jun 24, 2025 +2.45%
Congress pfp
Cliff Bentz R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 09, 2025 Jun 06, 2025 -4.40%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 19, 2025 May 14, 2025 +5.08%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $15,001 - $50,000
Jun 22, 2025 May 12, 2025 -1.33%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 06, 2025 May 05, 2025 -7.57%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -17.31%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -17.31%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc
Sale (Full) $15,001 - $50,000
May 15, 2025 Apr 15, 2025 -19.27%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
May 08, 2025 Apr 11, 2025 -16.68%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 09, 2025 -16.44%
Congress pfp
Robert Bresnahan R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
May 08, 2025 Apr 08, 2025 -23.88%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -11.57%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 19, 2025 -3.24%
Congress pfp
Daniel Meuser R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Aug 20, 2025 Feb 11, 2025 -5.51%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 22, 2025 +3.78%
Congress pfp
Emily Randall D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +8.39%
Congress pfp
Virginia Foxx R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +4.39%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Dec 05, 2024 Nov 15, 2024 -4.38%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 12, 2024 -7.91%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 14, 2024 -18.84%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 11, 2024 -20.91%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Partial) $1,001 - $15,000
Oct 10, 2024 Sep 17, 2024 -25.64%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Oct 04, 2024 Sep 09, 2024 -27.33%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN C�������: OUR BROKER PURCHASED SHARES OF 29 STOCKS IN MY SPOUSE'S ROTH IRA ON 8/7/24 IN ORDER TO REBALANCE THE PORTFOLIO IN ACCORDANCE WITH THE FIRM'S INVESTMENT STRATEGY FOR ACCOUNTS THAT SIZE. HE FAILED TO NOTIFY ME OF THESE TRANSACTIONS AND IT WASN'T DISCOVERED UNTIL I WAS ATTEMPTING TO RECONCILE OUR INVESTMENT HOLDINGS FOR MY 2024 FINANCIAL DISCLOSURE. SP AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 03, 2025 Aug 07, 2024 -29.85%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $50,001 - $100,000
Aug 20, 2024 Aug 07, 2024 -29.85%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -32.82%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2024 Aug 02, 2024 -32.82%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -32.82%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -22.01%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 -22.01%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Jun 05, 2024 May 29, 2024 -22.39%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -38.15%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -38.19%
Congress pfp
Michael C. Burgess R / House
AMGN logo
AMGN AMGEN INC.
Sale $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -37.59%